Translating Evidence into Practice: Use of Statins in Real-World Patients with Heart Failure

Rosamond, 2008, Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 117, e25, 10.1161/CIRCULATIONAHA.107.187998 Ghali, 1990, Trends in hospitalization rates for heart failure in the United States, 1973–1986. Evidence for increasing population prevalence, Arch Intern Med, 150, 769, 10.1001/archinte.1990.00390160043010 McMurray, 2000, Epidemiology, aetiology, and prognosis of heart failure, Heart, 83, 596, 10.1136/heart.83.5.596 Curtis, 2008, Incidence and prevalence of heart failure in the elderly, 1994–2008, Arch Intern Med, 168, 418, 10.1001/archinternmed.2007.80 Institute of Medicine, 2001 Masoudi, 2004, National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction, Circulation, 110, 724, 10.1161/01.CIR.0000138934.28340.ED Peterson, 2006, Association between hospital process performance and outcomes among patients with acute coronary syndromes, JAMA, 295, 1912, 10.1001/jama.295.16.1912 Fonarow, 2007, Association between performance measures and clinical outcomes for patients hospitalized with heart failure, JAMA, 297, 61, 10.1001/jama.297.1.61 Jha, 2005, Care in U.S. hospitals—the Hospital Quality Alliance program, N Engl J Med, 353, 265, 10.1056/NEJMsa051249 Williams, 2005, Quality of care in U.S. hospitals as reflected by standardized measures, 2002–2004, N Engl J Med, 353, 255, 10.1056/NEJMsa043778 Fonarow, 2004, Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design, Am Heart J, 148, 43, 10.1016/j.ahj.2004.03.004 Fonarow, 2005, Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry, Arch Intern Med, 165, 1469, 10.1001/archinte.165.13.1469 Fonarow, 2007, Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry, Am Heart J, 154, 12, 10.1016/j.ahj.2007.03.030 LaBresh, 2004, Get with the guidelines for cardiovascular secondary prevention: pilot results, Arch Intern Med, 164, 203, 10.1001/archinte.164.2.203 Centers for Medicare and Medicaid. Available at: www.cms.hhs.gov/quality/hospital Accessed February 1, 2008. Fonarow, 2007, Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF), Arch Intern Med, 167, 1493, 10.1001/archinte.167.14.1493 Bonow, 2005, Circulation, 112, 1853, 10.1161/CIRCULATIONAHA.105.170072 Krumholz, 2000, Evaluating quality of care for patients with heart failure, Circulation, 101, E122, 10.1161/01.CIR.101.12.e122 Hernandez, 2007, Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure, JAMA, 298, 1525, 10.1001/jama.298.13.1525 Bhatt, 2006, International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis, JAMA, 295, 180, 10.1001/jama.295.2.180 Ko, 2004, Lipid-lowering therapy with statins in high-risk elderly patients: the treatment–risk paradox, JAMA, 291, 1864, 10.1001/jama.291.15.1864 Anker, 2006, Statin use and survival in patients with chronic heart failure—results from two observational studies with 5200 patients, Int J Cardiol, 112, 234, 10.1016/j.ijcard.2006.03.057 Domanski, 2007, Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]), Am J Cardiol, 99, 1448, 10.1016/j.amjcard.2006.12.080 Krum, 2007, Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II, Cardiology, 108, 28, 10.1159/000095629 Foody, 2006, Statins and mortality among elderly patients hospitalized with heart failure, Circulation, 113, 1086, 10.1161/CIRCULATIONAHA.105.591446 Go, 2006, Statin therapy and risks for death and hospitalization in chronic heart failure, JAMA, 296, 2105, 10.1001/jama.296.17.2105 Cabana, 1999, Why don't physicians follow clinical practice guidelines? A framework for improvement, JAMA, 282, 1458, 10.1001/jama.282.15.1458 Carruthers, 1999, Assimilating new therapeutic interventions into clinical practice: How does hypertension compare with other therapeutic areas?, Am Heart J, 138, 256, 10.1016/S0002-8703(99)70319-4 Eisenberg, 1985, Physician utilization. The state of research about physicians' practice patterns, Med Care, 23, 461, 10.1097/00005650-198505000-00010 Lomas, 1989, Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians, N Engl J Med, 321, 1306, 10.1056/NEJM198911093211906 Bero, 1998, Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group, BMJ, 317, 465, 10.1136/bmj.317.7156.465 Greco, 1993, Changing physicians' practices, N Engl J Med, 329, 1271, 10.1056/NEJM199310213291714 Boekeloo, 1990, Strategies for increasing house staff management of cholesterol with inpatients, Am J Prev Med, 6, 51 Winkens, 1995, Randomised controlled trial of routine individual feedback to improve rationality and reduce numbers of test requests, Lancet, 345, 498, 10.1016/S0140-6736(95)90588-X Oxman, 1995, No magic bullets: a systematic review of 102 trials of interventions to improve professional practice, CMAJ, 153, 1423 Patel, 2004, State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction, J Am Coll Cardiol, 44, 192, 10.1016/j.jacc.2004.03.070 Davis, 1995, Changing physician performance. A systematic review of the effect of continuing medical education strategies, JAMA, 274, 700, 10.1001/jama.1995.03530090032018 Soumerai, 1998, Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial, JAMA, 279, 1358, 10.1001/jama.279.17.1358 LaPointe, 2006, Multifaceted intervention to promote beta-blocker use in heart failure, Am Heart J, 151, 992, 10.1016/j.ahj.2005.06.038 Ansari, 2003, Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure, Circulation, 107, 2799, 10.1161/01.CIR.0000070952.08969.5B Fonarow, 2001, Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP), Am J Cardiol, 87, 819, 10.1016/S0002-9149(00)01519-8 Butler, 2006, Improved compliance with quality measures at hospital discharge with a computerized physician order entry system, Am Heart J, 151, 643, 10.1016/j.ahj.2005.05.007 Johnston, 1994, Effects of computer-based clinical decision support systems on clinician performance and patient outcome. A critical appraisal of research, Ann Intern Med, 120, 135, 10.7326/0003-4819-120-2-199401150-00007 Doran, 2006, Pay-for-performance programs in family practices in the United Kingdom, N Engl J Med, 355, 375, 10.1056/NEJMsa055505 Glickman, 2007, Pay for performance, quality of care, and outcomes in acute myocardial infarction, JAMA, 297, 2373, 10.1001/jama.297.21.2373 Newby, 2006, Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease, Circulation, 113, 203, 10.1161/CIRCULATIONAHA.105.505636 O'Connor, 2006, Improving medication adherence: challenges for physicians, payers, and policy makers, Arch Intern Med, 166, 1802, 10.1001/archinte.166.17.1802 Ellis, 2000, Adherence to pharmacological interventions. Current trends and future directions. The Pharmacological Intervention Working Group, Control Clin Trials, 21, 218S, 10.1016/S0197-2456(00)00082-9 Lee, 2006, Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial, JAMA, 296, 2563, 10.1001/jama.296.21.joc60162